Table 3.

The relations of the categorical variables to the incidence of GI adverse events of cinacalcet.

Categorical variables	Cinacalcet group with adverse events, N = 12	Cinacalcet group without adverse events, N = 11	Odds ratio	95% CI
Sex (male)	66.7% (8/12)	63.6% (7/11)	1.14	0.21–6.37
Antacids	75% (9/12)	90.9% (10/11)	0.30	0.03–3.43
History of upper GI diseases	50.0% (6/12)	27.3% (3/11)	2.67	0.47–15.3
Gallbladder polyps	41.7% (5/12)	27.3% (3/11)	1.91	0.33–11.0
Gallstones	75% (9/12)	18% (2/11)	13.5	1.80–101